These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35791609)

  • 1. PTPRJ is downregulated in cervical squamous cell carcinoma.
    Roychowdhury A; Basu M; Pal D; Dutta P; Samadder S; Mondal R; Roy AK; Roychoudhury S; Panda CK
    J Genet; 2022; 101():. PubMed ID: 35791609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
    Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
    Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A.
    Yan CM; Zhao YL; Cai HY; Miao GY; Ma W
    Oncol Rep; 2015 Apr; 33(4):1737-44. PubMed ID: 25634668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.
    Casagrande S; Ruf M; Rechsteiner M; Morra L; Brun-Schmid S; von Teichman A; Krek W; Schraml P; Moch H
    J Pathol; 2013 Mar; 229(4):525-34. PubMed ID: 23007793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma.
    Roychowdhury A; Pal D; Basu M; Samadder S; Mondal R; Roy A; Roychoudhury S; Panda CK
    Cell Signal; 2023 Sep; 109():110735. PubMed ID: 37257769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.
    Smart CE; Askarian Amiri ME; Wronski A; Dinger ME; Crawford J; Ovchinnikov DA; Vargas AC; Reid L; Simpson PT; Song S; Wiesner C; French JD; Dave RK; da Silva L; Purdon A; Andrew M; Mattick JS; Lakhani SR; Brown MA; Kellie S
    PLoS One; 2012; 7(7):e40742. PubMed ID: 22815804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.
    Paduano F; Dattilo V; Narciso D; Bilotta A; Gaudio E; Menniti M; Agosti V; Palmieri C; Perrotti N; Fusco A; Trapasso F; Iuliano R
    FEBS J; 2013 Jan; 280(2):401-12. PubMed ID: 22564856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.
    Bilotta A; Dattilo V; D'Agostino S; Belviso S; Scalise S; Bilotta M; Gaudio E; Paduano F; Perrotti N; Florio T; Fusco A; Iuliano R; Trapasso F
    Oncotarget; 2017 Feb; 8(6):10091-10102. PubMed ID: 28052032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli.
    Dave RK; Dinger ME; Andrew M; Askarian-Amiri M; Hume DA; Kellie S
    PLoS One; 2013; 8(6):e68306. PubMed ID: 23840844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
    Iervolino A; Iuliano R; Trapasso F; Viglietto G; Melillo RM; Carlomagno F; Santoro M; Fusco A
    Cancer Res; 2006 Jun; 66(12):6280-7. PubMed ID: 16778204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk.
    Laczmanska I; Sasiadek MM
    J Appl Genet; 2019 Feb; 60(1):57-62. PubMed ID: 30661225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice.
    Yu Y; Shintani T; Takeuchi Y; Shirasawa T; Noda M
    J Neurosci; 2018 Sep; 38(39):8345-8363. PubMed ID: 30082414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
    Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
    Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of human riboflavin transporter 2(hRFT2) in cervical cancers from Uighur women.
    Ma JQ; Kurban S; Zhao JD; Li QZ; Hasimu A
    Asian Pac J Cancer Prev; 2014; 15(6):2485-9. PubMed ID: 24761851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
    Waldt N; Scharnetzki D; Kesseler C; Kirches E; Stroscher N; Böhmer FD; Mawrin C
    J Neurol Sci; 2020 Jan; 408():116553. PubMed ID: 31715329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DKK-1 gene methylation in exfoliated cells of cervical squamous cell carcinoma and its relationship with high risk HPV infection.
    He YH; Su RJ; Zheng J
    Arch Gynecol Obstet; 2021 Sep; 304(3):743-750. PubMed ID: 33547934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
    Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
    Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.
    Zhou Y; Hao Y; Li Y; Li R; Wu R; Wang S; Fang Z
    BMC Cancer; 2017 Mar; 17(1):230. PubMed ID: 28356144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.